TELA Bio (TELA) Competitors $0.96 -0.01 (-1.28%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$0.96 +0.00 (+0.46%) As of 04/25/2025 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TELA vs. BWAY, CATX, LAKE, PROF, ZJYL, SKIN, SGHT, KRMD, LUCD, and OBIOShould you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include BrainsWay (BWAY), Perspective Therapeutics (CATX), Lakeland Industries (LAKE), Profound Medical (PROF), Jin Medical International (ZJYL), Beauty Health (SKIN), Sight Sciences (SGHT), KORU Medical Systems (KRMD), Lucid Diagnostics (LUCD), and Orchestra BioMed (OBIO). These companies are all part of the "medical equipment" industry. TELA Bio vs. BrainsWay Perspective Therapeutics Lakeland Industries Profound Medical Jin Medical International Beauty Health Sight Sciences KORU Medical Systems Lucid Diagnostics Orchestra BioMed BrainsWay (NASDAQ:BWAY) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, community ranking, valuation, media sentiment, analyst recommendations and risk. Is BWAY or TELA more profitable? BrainsWay has a net margin of 3.88% compared to TELA Bio's net margin of -60.49%. BrainsWay's return on equity of 3.52% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets BrainsWay3.88% 3.52% 2.26% TELA Bio -60.49%-556.18%-63.13% Does the media favor BWAY or TELA? In the previous week, BrainsWay had 4 more articles in the media than TELA Bio. MarketBeat recorded 7 mentions for BrainsWay and 3 mentions for TELA Bio. BrainsWay's average media sentiment score of 1.26 beat TELA Bio's score of 0.92 indicating that BrainsWay is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrainsWay 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TELA Bio 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation and earnings, BWAY or TELA? BrainsWay has higher earnings, but lower revenue than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than BrainsWay, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBrainsWay$41.02M4.24-$4.20M$0.1754.18TELA Bio$69.30M0.55-$46.66M-$1.39-0.69 Do insiders & institutionals have more ownership in BWAY or TELA? 30.1% of BrainsWay shares are owned by institutional investors. Comparatively, 94.3% of TELA Bio shares are owned by institutional investors. 19.0% of BrainsWay shares are owned by company insiders. Comparatively, 6.0% of TELA Bio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community believe in BWAY or TELA? BrainsWay received 10 more outperform votes than TELA Bio when rated by MarketBeat users. However, 74.07% of users gave TELA Bio an outperform vote while only 67.31% of users gave BrainsWay an outperform vote. CompanyUnderperformOutperformBrainsWayOutperform Votes7067.31% Underperform Votes3432.69% TELA BioOutperform Votes6074.07% Underperform Votes2125.93% Which has more risk and volatility, BWAY or TELA? BrainsWay has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.98, indicating that its stock price is 2% less volatile than the S&P 500. Do analysts rate BWAY or TELA? BrainsWay currently has a consensus target price of $13.17, suggesting a potential upside of 42.96%. TELA Bio has a consensus target price of $7.25, suggesting a potential upside of 655.52%. Given TELA Bio's higher probable upside, analysts clearly believe TELA Bio is more favorable than BrainsWay.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BrainsWay 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00TELA Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 SummaryBrainsWay beats TELA Bio on 13 of the 17 factors compared between the two stocks. Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TELA vs. The Competition Export to ExcelMetricTELA BioSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$37.96M$4.29B$5.44B$7.80BDividend YieldN/A46.48%5.43%4.30%P/E Ratio-0.5730.2922.1418.40Price / Sales0.5552.52389.70101.29Price / CashN/A51.0838.2034.62Price / Book1.256.096.664.18Net Income-$46.66M$67.60M$3.21B$247.71M7 Day Performance0.36%4.51%6.16%6.56%1 Month Performance-25.61%-7.02%-2.86%-2.25%1 Year Performance-78.44%27.14%16.43%4.67% TELA Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TELATELA Bio2.2645 of 5 stars$0.96-1.3%$7.25+655.5%-78.1%$37.96M$69.30M-0.57120Short Interest ↓Gap UpBWAYBrainsWay3.6417 of 5 stars$8.32-1.7%$13.17+58.3%+91.9%$156.99M$41.02M83.21120News CoveragePositive NewsGap UpCATXPerspective Therapeutics3.2429 of 5 stars$2.05+5.1%$12.75+522.0%N/A$151.81M$1.43M0.0070Gap UpLAKELakeland Industries4.895 of 5 stars$15.95-0.5%$28.25+77.1%+0.7%$151.51M$151.82M-177.221,800Analyst UpgradeShort Interest ↑PROFProfound Medical1.9326 of 5 stars$4.76+1.5%$14.25+199.4%-40.7%$142.99M$10.68M-3.55150Analyst ForecastNews CoverageGap UpZJYLJin Medical InternationalN/A$0.87+18.7%N/A-77.2%$135.87M$23.50M0.00245News CoveragePositive NewsSKINBeauty Health1.9649 of 5 stars$1.00-4.8%$2.50+150.0%-67.6%$125.25M$334.29M-2.381,030Positive NewsSGHTSight Sciences2.9053 of 5 stars$2.41+1.3%$3.83+59.1%-37.4%$123.71M$79.87M-2.36210Upcoming EarningsNews CoverageKRMDKORU Medical Systems3.0179 of 5 stars$2.46+7.0%$4.70+91.1%+12.8%$113.05M$33.65M-9.8480News CoverageLUCDLucid Diagnostics2.4714 of 5 stars$1.19+1.7%$3.40+185.7%+98.5%$108.00M$4.35M-1.0470News CoverageHigh Trading VolumeOBIOOrchestra BioMed1.7108 of 5 stars$2.80-6.0%$15.00+435.7%-37.4%$107.28M$2.64M-1.744Analyst ForecastGap Down Related Companies and Tools Related Companies BrainsWay Competitors Perspective Therapeutics Competitors Lakeland Industries Competitors Profound Medical Competitors Jin Medical International Competitors Beauty Health Competitors Sight Sciences Competitors KORU Medical Systems Competitors Lucid Diagnostics Competitors Orchestra BioMed Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TELA) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TELA Stock Free TELA Stock Alerts